Paperpal Prime Logo

European Heart Journal, Supplement : Impact Factor & More

eISSN: 1554-2815pISSN: 1520-765X

Key Metrics

CiteScore
2.4
Impact Factor
< 5
SJR
Q3Cardiology and Cardiovascular Medicine
SNIP
0.43
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on European Heart Journal, Supplement

European Heart Journal, Supplement Journal Specifications

Indexed in the following public directories

  • Web of Science Web of Science
  • Scopus Scopus
  • SJR SJR
Overview
Publisher OXFORD UNIV PRESS
Language English
Frequency Bi-monthly
General Details
LanguageEnglish
FrequencyBi-monthly
Publication Start Year1999
Publisher URLVisit website
Website URLVisit website
View less

Planning to publish in European Heart Journal, Supplement ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in European Heart Journal, Supplement

Transcriptome analysis of changes associated with dexrazoxane or GDF15 pretreatment to protect against doxorubicin in human embryonic stem cell-derived cardiomyocytes
  • 3 Aug 2026
  • European Heart Journal Supplements
Feasibility and growth of a dedicated cardio-oncology service at a large victorian tertiary cardiac centre
  • 3 Aug 2026
  • European Heart Journal Supplements
Baseline cardiovascular assessment and incidence of major adverse cardiovascular events during immune checkpoint inhibitor therapy in a hungarian population
  • 3 Aug 2026
  • European Heart Journal Supplements
Angiotensin II unmasks immune checkpoint inhibitor-induced arrhythmias and conduction defects in mice
  • 3 Aug 2026
  • European Heart Journal Supplements
May Measurement Month 2023: results of an opportunistic blood pressure screening campaign in United Arab Emirates
  • 14 Jul 2026
  • European Heart Journal Supplements
May Measurement Month 2023: an analysis of blood pressure screening results from Oman
  • 6 Jul 2026
  • European Heart Journal Supplements
Transcriptome analysis of changes associated with dexrazoxane or GDF15 pretreatment to protect against doxorubicin in human embryonic stem cell-derived cardiomyocytes
  • 3 Aug 2026
  • European Heart Journal Supplements
Feasibility and growth of a dedicated cardio-oncology service at a large victorian tertiary cardiac centre
  • 3 Aug 2026
  • European Heart Journal Supplements
Baseline cardiovascular assessment and incidence of major adverse cardiovascular events during immune checkpoint inhibitor therapy in a hungarian population
  • 3 Aug 2026
  • European Heart Journal Supplements
Angiotensin II unmasks immune checkpoint inhibitor-induced arrhythmias and conduction defects in mice
  • 3 Aug 2026
  • European Heart Journal Supplements
May Measurement Month 2023: results of an opportunistic blood pressure screening campaign in United Arab Emirates
  • 14 Jul 2026
  • European Heart Journal Supplements
May Measurement Month 2023: an analysis of blood pressure screening results from Oman
  • 6 Jul 2026
  • European Heart Journal Supplements

FAQs on European Heart Journal, Supplement